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Timely disassembly of viral core composed of self-assembled capsid (CA) in infected
host cells is crucial for retroviral replication. Extensive in vitro studies to date on the
self-assembly/disassembly mechanism of human immunodeficiency virus type 1 (HIV-1)
CA have revealed its core structure and amino acid residues essential for CA–CA
intermolecular interaction. However, little is known about in vitro properties of HIV-2
CA. In this study, we comparatively analyzed the polymerization properties of bacterially
expressed HIV-1 and HIV-2 CA proteins. Interestingly, a much higher concentration of
NaCl was required for HIV-2 CA to self-assemble than that for HIV-1 CA, but once
the polymerization started, the reaction proceeded more rapidly than that observed
for HIV-1 CA. Analysis of a chimeric protein revealed that N-terminal domain (NTD)
is responsible for this unique property of HIV-2 CA. To further study the molecular
basis for different in vitro properties of HIV-1 and HIV-2 CA proteins, we determined
thermal stabilities of HIV-1 and HIV-2 CA NTD proteins at several NaCl concentrations by
fluorescent-based thermal shift assays. Experimental data obtained showed that HIV-2
CA NTD was structurally more stable than HIV-1 CA NTD. Taken together, our results
imply that distinct in vitro polymerization abilities of the two CA proteins are related to
their structural instability/stability, which is one of the decisive factors for viral replication
potential. In addition, our assay system described here may be potentially useful for
searching for anti-CA antivirals against HIV-1 and HIV-2.
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INTRODUCTION
Highly ordered core structure of human immunodeficiency virus type 1 (HIV-1) consisting
of multimeric capsid (CA) proteins is essential for modulating the complex virus replication
(Freed and Martin, 2013; Goff, 2013). While unusual stabilization by mutations in CA abrogates
viral infectivity through incomplete reverse transcription of viral genome (Forshey et al., 2002),
rhesus α-isoform of tripartite motif-containing protein 5 (TRIM5α) eliminates viral infectivity by
abnormally promoting disassembly of CA proteins (Forshey et al., 2005; Sebastian and Luban, 2005;
Stremlau et al., 2006). A variety of host proteins have been reported to regulate CA disassembly:
cyclophilin A (CypA) (Braaten et al., 1996a,b; Gamble et al., 1996), PDZ domain-containing
protein 8 (PDZD8) (Henning et al., 2010; Guth and Sodroski, 2014), cleavage and polyadenylation
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specificity factor (CPSF) (Lee et al., 2010; Price et al., 2012),
and myxovirus resistance protein 2 (MX2) (Goujon et al., 2013;
Kane et al., 2013; Liu et al., 2013). Thus, proper disassembly of
the CA-core structure in the viral replication cycle in concert
with cellular proteins is critical for HIV-1 infectivity. Given
that the process of HIV-1 CA core dissociation in infected
cells is intricately mediated by numerous viral and cellular
factors, in vitro model systems that mimic the in vivo situation
to a certain extent are required to gain definite insights into
molecular events in HIV-1 core formation/deformation. In fact,
various in vitro systems have been developed to study the
physicochemical aspects of HIV-1 CA–CA interaction (Ehrlich
et al., 1992; Campbell and Vogt, 1995; Gross et al., 1997; von
Schwedler et al., 1998; Gross et al., 2000; Ehrlich et al., 2001;
Lanman et al., 2002; Mateu, 2002; Morikawa et al., 2004; Alfadhli
et al., 2005; del Alamo et al., 2005; Lidon-Moya et al., 2005; Chen
and Tycko, 2010). Although the above systems are influenced by
numerous factors, such as ion strength, temperature, pH, and
crowding agents, a high concentration of NaCl has been generally
and frequently used to initiate the CA-assembly in vitro.
HIV CA consists of two globular domains [N-terminal
domain (NTD) and C-terminal domain (CTD)], and a linker
domain connecting these two domains (Figure 1A). While HIV-1
CA NTD has an N-terminal β-hairpin and seven α-helices in the
downstream region (Gitti et al., 1996; Momany et al., 1996), its
CA CTD has four α-helices (Gamble et al., 1997; Du et al., 2011).
The former primarily forms a hexameric structure (also forms a
pentameric structure), and the latter interacts with the NTD of
adjacent CA molecules (Pornillos et al., 2009, 2011). CTD also
forms a CTD-CTD dimer (Ganser-Pornillos et al., 2007; Pornillos
FIGURE 1 | Structural comparison of NL4-3 and GL-AN Gag-CA proteins. (A) Alignment of NL4-3 and GL-AN Gag-CA sequences. CA amino acid sequences of
HIV-1 NL4-3 (GenBank accession number: AF324493) and HIV-2 GL-AN (GenBank accession number: M30895) are aligned. The N-terminal domain (NTD), linker
domain, C-terminal domain (CTD), β-hairpin, and helices 1 to 11 (H1 to H11) are shown based on previous studies (Gamble et al., 1996; von Schwedler et al., 2003;
Robinson et al., 2014; Gres et al., 2015). (B) Superimposition of the NTD structures. Superposed structures of HIV-1 NTD (green, PDB code: 3H4E) and HIV-2 NTD
(gray, PDB code: 2WLV) were depicted by PyMOL ver 1.8.
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FIGURE 2 | In vitro polymerization features of NL4-3 and GL-AN CA proteins. Polymerization reaction was carried out and monitored by OD at 350 nm as described
in MATERIALS AND METHODS. (A) SDS-PAGE profile. The purity of CA proteins was checked by SDS-PAGE gel stained with Coomassie Brilliant Blue. Size
markers in kDa (on the left) and the CA proteins (arrows) are indicted. NLCA, NL4-3 CA; GLCA, GL-AN CA. (B–E) Self-polymerization of CA proteins. Purified CA
proteins were added to the buffer containing various concentrations of NaCl, and incubated for 4 h (B–C) or 10 min (D–E) at room temperature. Polymerized
products and polymerization kinetics at various concentrations of NaCl were determined by OD at 350 nm for NLCA (B,D) and GLCA (C,E) as shown.
FIGURE 3 | Tubular structures of in vitro assembled NL4-3 and GL-AN CA proteins. CA proteins were fully polymerized in vitro, fixed by glutaraldehyde, and
visualized via TEM as previously described (Sakaguchi et al., 2002; Piroozmand et al., 2006). (A,B) represent micrographs of HIV-1 NL4-3 CA (NLCA) and HIV-2
GL-AN CA (GLCA), respectively. Scale bars: 1 µm in upper panels; 200 nm in lower panels.
et al., 2009). Based on cryo-electron microscopy studies, it has
been proposed that HIV-1 cores in mature virions have a mixture
of approximately 250 hexameric CA proteins and 12 pentameric
CA proteins at upper and lower ends of the conical core (Ganser
et al., 1999; Zhao et al., 2013). In vitro studies have also shown
that HIV-1 CA is assembled to form core-like structure made
up of hexameric CA proteins, a structure similar to the core
in native virions (Ganser et al., 1999; Byeon et al., 2009; Zhao
et al., 2013). Of note, this self-assembly process of HIV-1 CA
(monomers, hexamers, and final core-like products consisting of
hexamers) can be induced by high ionic strength, and readily
monitored by simple turbidity assays in vitro (Ehrlich et al., 1992;
Li et al., 2000; Ganser-Pornillos et al., 2004; Barklis et al., 2009).
Moreover, as described above, CA disassembly process regulated
by CA inhibitors/host proteins, such as TRIM5α, CypA, and
PDZD8, can be experimentally analyzed in vitro as well as in vivo
Frontiers in Microbiology | www.frontiersin.org 3 June 2017 | Volume 8 | Article 1082
fmicb-08-01082 June 13, 2017 Time: 12:7 # 4
Miyazaki et al. Capsid Proteins of HIV-1/HIV-2
(Grattinger et al., 1999; Ternois et al., 2005; Black and Aiken,
2010; Guth and Sodroski, 2014).
Amino acid sequences of HIV-1/HIV-2 CA proteins are
significantly related to each other (Figure 1A), and more
strikingly, their NTD 3-D structures are highly similar
(Figure 1B). However, although HIV-1 and HIV-2 exhibit
distinct biological properties associated with their CA proteins
(Freed and Martin, 2013), to the best of our knowledge, in vitro
properties of HIV-2 CA have been very poorly studied so
far. HIV-2 is a medically and socially important retrovirus
in addition to HIV-1, and is important for basic virology as
well. In this study, we comparatively analyzed the in vitro
polymerization properties of HIV-1/HIV-2 CA proteins, and
also their thermal stability. We found that HIV-1 and HIV-
2 CA proteins are remarkably different from each other in
these characteristics, and demonstrated that the observed
difference is attributable to the NTD of CA proteins. Our
results here suggest that the structural instability/stability of




Sequences encoding a full-length CA of HIV-1 NL4-3
(Pro1-Leu231 in Figure 1A) and its NTD (Pro1-Tyr145
in Figure 1A) were PCR-amplified and cloned into pET21
(EMD chemicals, Inc.) using Nde I and Xho I sites to generate
NLCA and NLNTD, respectively. Sequences encoding a full-
length CA of HIV-2 GL-AN (Pro1-Met231 in Figure 1A) and
its NTD (Pro1-Tyr145 in Figure 1A) were PCR-amplified
and cloned into pET21 as above to generate GLCA and
GLNTD, respectively. All mutant clones analyzed in this
study, designated NL/GL, GL32NLCA, and GLmtCA,
were generated by overlapping PCR. Infectious molecular
clones designated NL4-3 and GL-AN have been previously
described (Adachi et al., 1986; Shibata et al., 1990; Kawamura
et al., 1994). NL4-3 and GL-AN are prototype full-length
clones of HIV-1 and HIV-2, respectively, and frequently
and widely used for various HIV studies as representative
clones.
Expression and Purification of CA
Proteins
Recombinant CA proteins (tagged with poly-histidine at
the C-terminus) were expressed in E. coli strain BL21
(DE3) RIL (Agilent technologies) and purified as previously
described (Li et al., 2000). Expression of wild-type and mutant
CA proteins were induced with 0.1 mM isopropyl β-D-
thiogalactopyranoside. Recombinant proteins were then
purified by immobilized metal affinity chromatography
(TALON, Clontech Laboratories Inc.), and their purities
were checked and confirmed by SDS-poly-acrylamide gel
electrophoresis (SDS-PAGE) for subsequent experimental uses
(Figure 2A).
FIGURE 4 | Comparative analysis of several CA proteins for their in vitro
polymerization properties. CA-polymerization was performed in vitro and
monitored by OD at 350 nm as described in MATERIALS AND METHODS.
(A) Polymerization of NL4-3 CA (NLCA), GL-AN CA (GLCA), and NL/GL CA
(NL/GL) proteins for 4 h at various NaCl concentrations. The chimeric clone
NL/GL has the sequence encoding the NTD of NL4-3 CA and the linker
domain/CTD of GL-AN CA (Figure 1A). (B) Polymerization kinetics of NL and
NL/GL CA proteins (1.5 M NaCl). (C) Polymerization of NL and GL32NL CA
proteins for 4 h at various NaCl concentrations. GL32NL is a chimeric
NLCA-derivative clone which has the sequence encoding the very N-terminal
region of GL-AN CA (Pro1-Phe32 in Figure 1A).
In Vitro Assay for HIV CA Assembly
Assays for CA assembly were performed similarly as described
previously (Ehrlich et al., 1992; Li et al., 2000; Ganser-
Pornillos et al., 2004; Barklis et al., 2009). Three independent
polymerization experiments were carried out, and mean
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FIGURE 5 | Comparison of in vitro polymerization activity of GL-AN and mutant CA proteins. (A) CA–CA interacting surface of HIV-1. Two CA molecules (greenish
and bluish) are shown. Three amino acids (M39, T54, and T58 in the H2–H3 region) critical for the interaction are highlighted as shown (see Pornillos et al., 2009,
2011 for details). The structure of HIV-1 CA (PDB code: 3H4E) was depicted by PyMOL ver 1.8. (B) Polymerization of parental and mutant CA proteins.
CA-polymerization was performed in vitro for 4 h at various NaCl concentrations, and monitored by OD at 350 nm as described in the Section “Materials and
Methods”. The mutant clone GLmtCA has three amino acid substitutions relative to GLCA as indicated.
values ± standard deviations are shown where indicated. CA
polymerization reactions were performed in 50 mM Tris-HCl
(pH 8.0) at a final concentration of 50 µM recombinant
CA proteins. Reactions were carried out at different NaCl
concentrations for the indicated time in each experiment.
Polymerized products were monitored by optical density (OD) at
350 nm using a spectrophotometer (DU730, Beckman–Coulter).
OD350 has been used to most sensitively measure the ordered
protein aggregates, not the protein itself. The upper OD detection
limit of DU730 is 3.0.
Transmission Electron Microscopy (TEM)
Negative staining and electron microscopy were performed
similarly as described before (Sakaguchi et al., 2002; Piroozmand
et al., 2006). NL4-3 and GL-AN CA proteins adjusted to
100 µM were in vitro polymerized in the presence of 2 M
NaCl (for NL4-3) or 3.5 M NaCl (for GL-AN) for 30 min
at room temperature. Assembled CA proteins were fixed by
0.2% glutaraldehyde, and were placed on formvar-carbon-coated
nickel grids, stained with 4% uranyl acetate, and examined by a
transmission electron microscope (Hitachi H-7650).
Fluorescence-based Thermal Shift Assay
Fluorescence-based thermal shift assays by differential
scanning fluorimetry (DSF) were carried out as described
previously (Niesen et al., 2007; Fedorov et al., 2012).
Three independent DSF experiments were conducted with
highly similar results. Fifty µM of CA NTD proteins were
prepared in 50 mM Tris-HCl (pH 8.0), 250–2000 mM NaCl
and 1 mM 2-mercaptethanol containing SYPRO orange
(Invitrogen) to quantify thermal stability. Temperature
gradient was set in the range of 25◦C to 95◦C with 1%
ramp rate using 7500 real-time PCR system (Applied
Biosystems). Melting temperature (Tm) of CA was calculated
by SYPRO orange fluorescence curves using 7500 software
ver. 2.03.
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FIGURE 6 | Thermal stability of CA NTD proteins derived from HIV-1 NL4-3,
and HIV-2 GL-AN. The thermal stability of NLCA and GLCA NTD proteins in
the presence of 250 mM NaCl was determined by DSF as described in the
Section “Materials and Methods”. SYPRO orange fluorescence intensity (FI) at
varying temperatures (upper panel) and derivative melt curves calculated by
differences in FI at each temperature (lower panel) are shown. Peak
temperatures in the curves (dFI/dT) were considered as Tm.
RESULTS
Polymerization Properties of HIV-1 and
HIV-2 CA Proteins
Capsid protein is a major component of retroviral particles, and
commonly plays an essential role for virus replication (Goff,
2013). Therefore, amino acid sequences in CA proteins and their
structural features are expected to be conserved among viruses,
especially those belonging to the same viral genus. Indeed, when
HIV-1 and HIV-2 CA proteins are compared (Figure 1), their
amino acid identities are around 70% (67% for NTD and 73%
for CTD), and structural outlines of NTD proteins as revealed
by nuclear magnetic resonance are highly similar (Price et al.,
2009). Nevertheless, we were interested in ascertaining if there
is some biochemical/biophysical difference(s) between the two
closely related CA molecules from HIV-1 and HIV-2 that may
potentially affect their biological properties.
To comparatively determine the physicochemical
characteristics of HIV-1 and HIV-2 CA proteins, we employed
the in vitro assembly system by NaCl (Ehrlich et al., 1992; Li et al.,
2000; Ganser-Pornillos et al., 2004; Barklis et al., 2009) in this
study. Recombinant CA proteins (derived from HIV-1 NL4-3
and HIV-2 GL-AN) expressed in bacteria and purified were
used for monitoring their polymerization reactions. As shown in
Figures 2B,C, a very prominent difference was noted between
NL4-3 and GL-AN CA proteins for their NaCl-dependent
polymerization. NL4-3 CA polymerized at a significant level with
1 M NaCl, and fully assembled with 1.5 M, 1.75 M, and 2 M NaCl.
In a sharp contrast, no polymerized products were detected for
GL-AN CA with 2.75 M and lower concentrations of NaCl.
At least 3 M NaCl or higher concentrations were required for
GL-AN CA to definitively detect the polymerization products.
We then performed kinetic studies to determine whether there
was any difference between NL4-3 and GL-AN CA proteins
(Figures 2D,E). As demonstrated, NL4-3 CA self-assembled in
a linear way over time with 1.5 M and 2.0 M NaCl, whereas
GL-AN CA exhibited Boltzmann shape curves with 3 M and 3.5
M NaCl even when OD values were very low (note the GLCA
right panel in Figure 2E). In total, GL-AN CA self-polymerized
more rapidly than NL4-3 CA once successfully triggered by
NaCl. Considering early reports on the TEM morphology of
in vitro HIV-1 CA products (Ehrlich et al., 1992; Campbell and
Vogt, 1995; Gross et al., 1997), we checked for the presence
of assembled CA proteins with a tubular or cylinder shape in
the reaction products. As shown in Figures 3A,B, polymers
with a similar morphology were readily observed in the in vitro
assembled products of NL4-3 and GL-AN CA proteins, as
previously described.
Polymerization Properties of CA
Chimeric and Mutant Proteins
Although the amino acid identities in NL4-3 and GL-AN CA
proteins are considerably high (Figure 1), their polymerization
properties in vitro were clearly distinct (Figure 2). To determine
the region in CA responsible for the observed differences, we
first constructed a chimeric clone between the two CA proteins
and designated it as NL/GL. NL/GL contains the NTD of
NL4-3 CA and the linker/CTD of GL-AN CA (Figure 1A). We
then performed the in vitro polymerization assays for NL4-3
CA, GL-AN CA, and NL/GL as described above. As clearly
seen in Figure 4A, NL/GL gave very similar results with those
obtained for NL4-3 CA, but very different from those for
GL-AN CA. Consistent with these results, NL/GL polymerization
kinetics were highly similar to those of NL4-3 CA (Figure 4B).
We concluded that NTD determines differences in in vitro
polymerization properties of NL4-3 and GL-AN CA proteins.
It has been reported that the N-terminal β-hairpin structure
is important for CA assembly by analyzing a chimeric protein
between HIV-1 and murine leukemia virus CA proteins (Cortines
et al., 2011). This suggested that the most N-terminal region
containing the β-hairpin structure could be determinants for the
different polymerization phenotypes between NL4-3 and GL-AN
CA proteins. We therefore constructed a chimeric CA clone
designated GL32NLCA to test this possibility. The N-terminal
portion of NLCA (Pro1-Phe32 in Figure 1A) was replaced with
the corresponding region of GLCA to generate GL32NLCA.
Frontiers in Microbiology | www.frontiersin.org 6 June 2017 | Volume 8 | Article 1082
fmicb-08-01082 June 13, 2017 Time: 12:7 # 7
Miyazaki et al. Capsid Proteins of HIV-1/HIV-2
FIGURE 7 | Thermal stability of CA NTD proteins at various NaCl concentrations. The thermal stability of NLCA and GLCA NTD proteins at various NaCl
concentrations was evaluated as described in the legend to Figure 6. FI values and melt curves (A,B, respectively), and Tm shifts induced by NaCl (C) are shown.
As shown in Figure 4C, when NLCA and GL32NLCA were
monitored for the polymerization activity at various NaCl
concentrations, no significant difference was noted. This result
indicated that the region containing the N-terminal β-hairpin
structure is not a determinant for the distinct polymerization
properties.
Previous structural studies have shown that some amino acid
residues (no. 20, 38, 39, 42, 54, and 58 in CA) located at the
CA–CA interaction interface (regions of helices 1, 2, and 3) are
critical for polymerization (Pornillos et al., 2009, 2011). Of these
six residues, three, i.e., L20, P38, and A42, are conserved between
NL4-3 and GL-AN CA proteins (Figure 1A). Consequently, three
amino acids (no. 39, 54, and 58) are unshared, and reside in the
CA–CA interacting surface (Figure 5). We therefore introduced
three amino acid substitutions (G39M, Q54T, and C58T) into
GLCA to generate GLmtCA carrying residues of the NL4-3
CA type (Figure 5), and examined its polymerization ability.
GLmtCA was found to have much less polymerization activity
than GLCA (Figure 5B). This result indicated that amino acids
G39, Q54, and C58 are critical for self-assembly of GL-AN CA,
and that the amino acid substitutions introduced cannot change
its polymerization property to the NL4-3 type.
Thermal Stability of CA NTD Proteins
It has been reported that chemical chaperons, inhibitors
of HIV-1 CA polymerization, raise its Tm (Lampel et al.,
2013). Furthermore, previous studies have reported that higher
temperature facilitates the polymerization of HIV-1 CA (Ehrlich
et al., 1992; Morikawa et al., 2004; Alfadhli et al., 2005). Moreover,
the interaction of HIV CA with CypA or anti-retroviral
TRIM-Cyp, known to promote HIV CA dissociation (Braaten
et al., 1996a,b; Gamble et al., 1996; Forshey et al., 2005; Sebastian
and Luban, 2005; Stremlau et al., 2006), was shown to be
an exothermic event (Yoo et al., 1997; Price et al., 2009),
indicating that HIV CA is shifted to a more thermally stable
state upon binding to CypA or TRIM-Cyp. These results have
strongly suggested that the ability of CA to polymerize and
the thermal stability of CA are mutually linked. We therefore
comparatively determined the thermal stability of CA NTD
proteins derived from NL4-3 and GL-AN, the determinants
for distinct polymerization properties of the two CA proteins
(Figure 4).
To determine the Tm for the two proteins, we employed
fluorescence-based thermal shift assays using SYPRO orange.
Proteins expose hydrophobic patches upon heating. This assay
utilizes a chemical property of SYPRO orange to bind to
hydrophobic patches in target proteins, and therefore, their
denaturation states can be monitored by fluorescence intensities
from SYPRO orange. As shown in Figure 6, fluorescence
intensity curves of NL4-3 and GL-AN NTD proteins obtained
by this assay system were quite different, and Tm values for
NL4-3 NTD and GL-AN NTD were calculated to be 50.4 ◦C and
53.9 ◦C, respectively. Thus, GL-AN NTD was thermally more
stable than NL4-3 NTD. We further examined the effects of
NaCl, an agent to promote CA polymerization (Figure 2), on
the thermal stability of the two NTD proteins. Figure 7 shows
the results obtained. The Tm for NL4-3 NTD fell down (7.4 ◦C)
by increasing NaCl concentrations from 250 mM to 2000 mM
(Figures 7A,C). On the other hand, relatively mild effects were
observed for the Tm-shift of GL-AN NTD (2.1◦C falling down as
shown in Figures 7B,C). Thus, GL-AN NTD was less influenced
by NaCl with respect to thermal stability than NL4-3 NTD.
In other words, NL4-3 NTD was structurally destabilized to a
greater extent by NaCl than GL-AN NTD. Collectively, GL-AN
NTD was structurally more stable than NL4-3 NTD.
DISCUSSION
Although there have been numerous studies on the
assembly of HIV-1 CA in vitro (Ehrlich et al., 1992, 2001;
Campbell and Vogt, 1995; Gross et al., 1997, 2000; von
Schwedler et al., 1998; Lanman et al., 2002; Mateu, 2002;
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Morikawa et al., 2004; Alfadhli et al., 2005; del Alamo et al.,
2005; Lidon-Moya et al., 2005; Chen and Tycko, 2010), almost
no experimental investigations into the corresponding research
field of HIV-2 have been done as of yet. In this work, we
determined in vitro characteristics of HIV-2 CA (derived from
an infectious clone, GL-AN) in parallel with HIV-1 CA (derived
from an infectious clone, NL4-3). We confirmed previous
findings on HIV-1 CA, and newly found that HIV-2 CA
is strikingly distinct from HIV-1 CA regarding its in vitro
properties (Figures 2, 4, 6, 7) despite their sequence relatedness
and structural similarity (Figure 1). We demonstrated here
that much higher concentrations of NaCl are required for the
polymerization of HIV-2 CA than for HIV-1 CA, but that HIV-2
CA assembly proceeds more promptly relative to HIV-1 CA
after being initiated (Figures 2, 4). Although a specific narrow
region in CA was not identified as a determinant, NTD is
clearly responsible for this property (Figure 4). This conclusion
is quite reasonable because amino acid identities are higher
in CTD than those in NTD, and would be consistent with
the finding that intermolecular CTD-CTD interaction occurs
first and NTD-NTD interaction occurs as the final step (Grime
and Voth, 2012; Tsiang et al., 2012). NTD may function as a
rate-limiting factor for CA polymerization.
We also demonstrated by fluorescence-based thermal shift
assays that HIV-2 CA NTD is structurally more stable than HIV-1
CA NTD (Figures 6, 7). Thus, the thermal stability of NTD
proteins was inversely related with the polymerization ability
of CA proteins at lower NaCl concentrations (Figures 2, 4).
Although the molecular basis is still unknown, the negative
relationship between thermal stability and assembly property
has been reported for CA proteins of HIV-1 and its CA
mutant (Ganser-Pornillos et al., 2004; Cortines et al., 2015),
and for HIV-1 CA treated with chemical chaperons (Lampel
et al., 2013). Furthermore, HIV-1 CA polymerization was
facilitated by heat destabilization (Ehrlich et al., 1992; Morikawa
et al., 2004; Alfadhli et al., 2005; Barklis et al., 2009). Taken
together, it is not unreasonable to assume that the relatively
high thermal stability of CA is associated with the relatively
poor assembly property (i.e., high disassembly property) of
CA. However, whether the different sequence and/or structural
property of HIV-1/HIV-2 CA proteins needed to bind to
cellular restriction or regulation factors, such as TRIM5α
or CypA, are linked with our results described here is
unclear at present. The molecular basis underlying the distinct
in vitro features of HIV-1/HIV-2 CA proteins remains to be
elucidated.
HIV Gag-CA proteins play indispensable roles at various
steps in the viral replication cycle (Freed and Martin, 2013).
Our results described here clearly indicated that CA proteins of
HIV-1 and HIV-2 are biochemically distinct. The data on the
thermal stability of HIV-1/HIV-2 CA NTD proteins (Figures 6, 7)
may account for the unique polymerization properties of HIV-1
and HIV-2 CA proteins (Figures 2, 4). As for the biological
implications of our findings, we noticed a report showing that the
HIV-2 GH123 virus carrying an identical Gag-CA with GL-AN
exhibits faster uncoating (CA disassembly) kinetics in infected
cells relative to the HIV-1 NL4-3 virus (Takeda et al., 2015). This
observation is in good agreement with our results, supporting the
notion that the instability/stability of CA proteins may affect the
early viral replication phase (uncoating) of HIV-1 and HIV-2.
The plausibility of our concept needs to be biochemically and
biologically verified.
It is reasonable to consider Gag-CA as a therapeutic target,
and indeed, there have been numerous attempts in this direction
(Tang et al., 2003; Zhang et al., 2008; Tian et al., 2009; Blair
et al., 2010; Jin et al., 2010; Curreli et al., 2011; Shi et al., 2011;
Kortagere et al., 2012; Lemke et al., 2012; Lamorte et al., 2013;
Matreyek et al., 2013; Bhattacharya et al., 2014; Fricke et al.,
2014; Peng et al., 2014; Price et al., 2014). However, to the best
of our knowledge, none of the anti-viral inhibitors described
have proceeded to the steps to study their practical/clinical
use. In the present study, we have demonstrated the close
association of CA polymerization property in vitro and thermal
stability of CA NTD as monitored by DSF. Thermal stability
can be readily evaluated in large numbers simultaneously by a
real-time PCR machine. It is thus practical to identify compounds
by DSF that unusually destabilize or stabilize Gag-CA NTD
proteins of HIV-1/HIV-2. In fact, a small molecule named
PF74, previously reported to bind to HIV-1 CA and induce
premature HIV-1 uncoating (Shi et al., 2011), was found to
aberrantly increase the stability of NLCA NTD as revealed by
DSF in our pilot experiments (manuscript in preparation). The
system based on DSF (Figures 6, 7) represents a promising new
high-throughput screening method to search for durable and
effective anti-HIV CA antivirals from a large library of candidate
molecules.
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